No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms
- PMID: 29233939
- PMCID: PMC5754808
- DOI: 10.1073/pnas.1716644115
No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Comment in
-
Reply to Mohlin et al.: High levels of EPAS1 are closely associated with key features of low-risk neuroblastoma.Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):E10859-E10860. doi: 10.1073/pnas.1718429115. Epub 2017 Dec 12. Proc Natl Acad Sci U S A. 2017. PMID: 29233947 Free PMC article. No abstract available.
Comment on
-
Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression.Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6137-E6146. doi: 10.1073/pnas.1700655114. Epub 2017 Jul 10. Proc Natl Acad Sci U S A. 2017. PMID: 28696319 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
